NAPSA and squamous cell carcinoma: It is of note that other investigators have reported Napsin A positivity in 0–10% of pulmonary squamous cell carcinomas in studies analyzing 14–569 tumors [16, 18, 22, 24, 46–48, 50, 52, 57–59, 61–65, 67–69].